Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid

Novo Nordisk · Phase 3 · Terminated · Enrollment 2

NCT02417103

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
GLP-1 (Liraglutide)n/rn/rn/rn/r
Placebo Comparatorn/rn/rn/rn/r

Not shown

  • GLP-1 (Liraglutide): endpoint not reported
  • Placebo Comparator: endpoint not reported